We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Fitbug | FITB | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.1675 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.1675 | 0.1675 |
| Top Posts |
|---|
Posted at 27/4/2017 09:20 by mudbath It is unusual for the threat of an impending need for additional funding to be accompanied by the onset of a rising trend in the SP, as is the case currently with FITB.If the MMs continue to play this in in the fashion seen in recent weeks then the share price might soon creep back above 0.2,imo. One of these days,investors here might benefit in spades on being updated regarding trading prospects, or even on more radical developments. I would want to be IN when/if this occurs. |
Posted at 24/4/2017 11:10 by ravin146 Cpap read the last rns...Who are the investors in the last week...why buy in such large volume now? Private placement yes, though mm still need to forward sell.Exact pattern of last placing.Imo |
Posted at 12/4/2017 12:15 by transhoneyqueens Institutional investors would not be investing in this next round of funding unless big deals & sales are about to be signed , patience needed |
Posted at 12/4/2017 12:05 by jackson83 placing will not be for us private investors this time so price should recover well .. placing thought to be around 22p IMHO .. Institutional placing ... share price could double when announced |
Posted at 26/1/2017 08:09 by pwhite73 The leaving out of the financial figures was deliberate. The company new full well that investors would focus on the 14,000 employees and the fact that Asian company was global. There is a strong argument that the RNS was issued to deliberately mislead.The fact that the stock was suspended and a more expansive update issued a day later does suggest the company was aware it had created a false market in its shares. However the desired outcome was achieved. They raised £1 million to the detriment of many private investors. The one positive is that if they have signed a contract with a company that has 14,000 employees it may open avenues for a more lucrative contract. That's only if the story is true. |
Posted at 25/1/2017 11:29 by supercity Time and time again shares are ramped and spiked before a fund raisingTime and time again the more experienced investors put out a word of warning which gets shot downIt will continue to happen while there is a never ending line of new investors believing in the 'massive contract win' or 'takeover rumours' that fly aroundAbsolutely no surprise to see the fund raising - all the shares are no doubt sold to the 'believers' in the past week and they are the ones holding the big lossesMeanwhile funds are now in place to keep the directors employed for the future No doubt this will continue to drop - don't be fooled in to thinking getting in below the placing price is good - unless directors participate in it...(looks like they didn't) I bet the majority in the placing don't even hold their share now - we will see if any holdings rns are released |
Posted at 25/1/2017 08:40 by dusseldorf Unless anyone puts there hand up to say they were participants via a broker approach recently (placement with 'sophisticated investors'), I'd suggest the placement was similar to one a year or so ago i.e. Naked selling by MM's and stock is basically already in the hands of PI's, just that it was bought at higher levels. Effectively issue stock to raise money because there is demand.Doesn't change my stance on RTO prospects, but I feel for the investors who bought and held through spike, a right rogering. Not sure how NW1 will feel about it, I assume they were consulted. |
Posted at 22/1/2017 09:35 by phil1969 As has been pointed out recently, on 29th June 2016 it was announced that NW1 and Kifin would convert a total of £8.4m of loans into FITB stock worth just £840,000.At the same time, the interim CFO took the roll CFO on properly. Just in time to get issued 11m options. In the RNS, FITB are also keen to point out his experience in Mergers and acquisitions. "Tyler has worked with the Company as interim CFO since early December 2015. Prior to that Tyler has spent more than 10 years providing mergers and acquisitions advisory, debt placement, management consulting and interim CEO and CFO services to a wide variety of tech, media and electronics businesses." He has moved back to California and a new CFO put in place who also has experience of M&A after selling 48% of one of his last firms to private equity investors. Tyler has kept the door open to FITB and it's reported in the RNS "is available on an ad hoc basis". This is unusual if a new experienced CFO is in place so I can only assume Tyler was working on something which is still ongoing. Since June 29th 2016, there's more to FITB business model than the wellbeing industry. A merger or RTO is the most logical explanation NW1 and Kifin would convert the outstanding debt at the equivalent share price of 2.5p Plenty of upside and a buying opportunity at 0.3p if this is the case. I don't see FITB as a stock I would buy into off the back of its current operations. I view FITB like I do many shells but they also have a business which is currently a drain on cash. My 9m investment is risk/reward play on a merger or RTO with HPI, NW1, Kifin connections. I can't see wenesdays RNS and the subsequent ramping (and deramping) as the sole reason for the share price running away. It was an excellent opportunity for those 'in the know' to buy in quantity without being accused of insider trading. They were buying off the back of the 'news' ;-) which would also explain the £107k buy. There is no way that was a sell looking at the timings and price spike. Large investors who are showing huge losses didn't make their stock available to MM's on the spike. Looking at fridays updated holdings page on the FITB website. No one offloaded into the spike. A very cleverly timed no news RNS. You have to ask yourself if the order was delivered late December, why leave it nearly a month to announce. IMHO |
Posted at 16/1/2017 09:25 by twodegrees SPARK Advisory Partners Limited was formed in early 2012 by a group of senior corporate finance directors previously working in a large corporate finance and broking business.Our team of senior professionals is dedicated to providing high quality, timely and considered financial advice on a range of issues to corporate and private equity clients. With over 100 years of corporate finance experience, the team has a long track record of delivering value added advice to clients both on and off market. In today's turbulent world, existing and potential clients can be assured of the consistency and stability of service we provide, and rest in the knowledge that the team that they expect to work with is the team they will work with. Clients are guaranteed a partner-led approach. -Independent corporate finance specialists offering a full suite of advisory services across the capital (debt & equity) spectrum. -Expertise in IPO's for prospective Main Market, AIM and PLUS companies. -Impartial advice to companies and their directors, independent of brokers and investors - we will work with a range of brokers which allows us to match the most appropriate team to each opportunity. -Access to a wide and varied network of brokers, intermediaries, market professionals and investors, enhancing our ability to meet clients’ requirements. -Each of the Founding Partners is a significant shareholder in the business, along with private equity backer SPARK Ventures Limited. Website Industry Financial Services Type Privately Held Headquarters 5 St John’s Street, Farringdon, London, EC1M 4BH United Kingdom Company Size 1-10 employees Founded 2012 |
Posted at 05/7/2016 09:00 by mudbath It will be interesting to see how many shares will be bought in FITB via this crowdfunding venture."AIM-listed Fitbug looks to crowdfunding to raise capital for corporate wellness market push SyndicateRoom offers retail investors chance to take part in Fitbug's £2.6m fundraise Announcement follows SyndicateRoom's recent participation in FTSE 250 fundraise Funds will support wearable tech company's renewed focus on delivering digital wellness products and services to the B2B market Cambridge, UK - 5 July 2016 - SyndicateRoom, the equity crowdfunding platform, is offering its members the chance to take part in a share offer for AIM-quoted technology developer and digital wellness pioneer, Fitbug. SyndicateRoom will be the sole retail distribution agent for the fundraise and will offer EIS (Enterprise Investment Scheme) shares, on the same terms as institutional investors. Fitbug plans to raise £2.6 million during this raise. £852,000 has already been raised through institutional investors, with up to £1.76 million to be raised via SyndicateRoom and other investors at the same issue price. The funding round is expected to close by 25 July 2016. In August 2015, Anna Gudmundson was appointed Chief Executive of Fitbug. She is currently executing a turnaround drive for the business, moving the company's focus away from delivering wearable devices to an over-saturated B2C market, and instead, capitalising on the growing global corporate audience for digital wellness. The US corporate wellness market is forecast to grow 8.4% annually over the next 5 years to $12.1 billion, which demonstrates the potential in other markets. Digital wellness initiatives have proven to lead to reduced corporate costs associated with absenteeism, and to increased employee productivity. Fitbug has experienced an encouraging start to trading in 2016 with Q1 B2B sales in excess of £400,000, a significant increase over like for like sales in Q1 of 2015, providing validation for the new strategy. Furthermore, Fitbug anticipates a strong pipeline for the corporate market, forecasting in excess of £1.1m over expected contract lifetimes. Fitbug has identified a low cost entry point to market and at the end of April 2016, the company had approximately 100,000 users of its digital products. SyndicateRoom will provide Fitbug with previously untapped retail demand, in support of the company's capital needs. As the only crowdfunding platform to have intermediary status with the London Stock Exchange, SyndicateRoom is the only alternative investment platform offering retail investors access to both the public and private equity markets. Most recently, SyndicateRoom members participated in 3i Infrastructure PLC's £385m share placing, proving the platform is well placed to promote a diverse range of equity funding rounds, from early stage through to public companies. Anna Gudmundson, Chief Executive of Fitbug Holdings Plc, said, "Having assessed a range of finance options to support our short-term and long-term working capital needs, we were particularly excited by the prospect of offering new shares to investors via SyndicateRoom. With its recent membership of the London Stock Exchange, SyndicateRoom is the only platform that could effectively distribute our shares direct to crowdfund investors, enabling us to expand the number of owner-advocates for our business as we focus on becoming a leader within this space by delivering an innovative app-based technology to enhance employee wellness." SyndicateRoom CEO and co-Founder Goncalo de Vasconcelos said, "We're thrilled to provide our members the opportunity to take equity in another innovative and high growth business. In times of uncertainty and market volatility, companies will be looking outside of the traditional lending sector. Today's announcement highlights the importance of retail investors as an ever growing number of publicly listed companies are using SyndicateRoom to tap into retail investors demand. SyndicateRoom still remains the only crowdfunding platform that provides retail investors with direct access to company equity at the same economic terms as institutional investors." Tom Hinton, head of capital markets, SyndicateRoom commented, "Fitbug's decision to raise via SyndicateRoom demonstrates our unique ability to offer interesting capital market opportunities that can't be found elsewhere by retail investors. It's fantastic to see the platform helping companies access a broad pool of demand and market capital raises in such an innovative way." SyndicateRoom provides its members with access to the entire funding journey of growth businesses, from early-stage crowdfunding rounds through to high-growth IPOs and discounted placings." |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
